TerminatedPhase 1NCT01846429

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

Studying Malignant vascular tumor

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator: Amit Mahipal, M.D., MD
H. Lee Moffitt Cancer Center and Research Institute
Intervention: Sodium Bicarbonate(drug)
Enrollment: 9 enrolled
Eligibility: 18 years · All sexes
Timeline: 2013 – 2015

Study locations (1)

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Collaborators

Reliable Cancer Therapies

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01846429 on ClinicalTrials.gov

Other trials for Malignant vascular tumor

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT07582432
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Grifols Biologicals, LLC

See all trials for Malignant vascular tumor →

← Back to all trials